ProCE Banner Activity

ANRS Prévenir: Renal Safety of Different TDF/FTC Dosing Regimens for HIV PrEP

Slideset Download
Conference Coverage
Renal safety of daily TDF/FTC for PrEP acceptable, with few serious renal adverse events and none leading to permanent treatment discontinuation.


Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner


Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare